Drawing for M MENARINI MENARINI STEMLINE ONCOLOGY

USPTO serial 79347413

M MENARINI MENARINI STEMLINE ONCOLOGY

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
STEINPFAD, SARAH E
Law office
TMO LAW OFFICE 120 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with M MENARINI MENARINI STEMLINE ONCOLOGY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Arthur J. DeBaugh

Arthur J. DeBaugh Ward and Smith, P.A.751 Corporate Center DriveSuite 300Raleigh, NC 27607

Goods and services

ClassDescriptionStatusFirst use
005Diagnostic reagents for medical use; pharmaceutical preparations and substances for the treatment of cancerACTIVE—
042Biomedical research services; pharmaceutical products development; design and testing of new products; testing of pharmaceuticals; medical and pharmacological research services; research and development in the pharmaceutical and biotechnology fieldsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 25, 2025FINTFINAL DECISION TRANSACTION PROCESSED BY IB—
Jan 3, 2025FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jan 3, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Mar 17, 2024OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jan 17, 2024OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 17, 2024OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jan 2, 2024MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jan 2, 2024MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jan 2, 2024ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jan 2, 2024DOCKASSIGNED TO EXAMINER—
Jul 10, 2023RFNTREFUSAL PROCESSED BY IB—
Jun 15, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 15, 2023RFRRREFUSAL PROCESSED BY MPU—
May 6, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 5, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 28, 2023DOCKASSIGNED TO EXAMINER—
Mar 15, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 15, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 15, 2023ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Mar 15, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 15, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 15, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Oct 25, 2022OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Aug 30, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 24, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 22, 2022LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Aug 12, 2022SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance